GNS logo

Genus plc Stock Price

LSE:GNS Community·UK£1.7b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 10 Fair Values set on narratives written by author

GNS Share Price Performance

UK£25.45
5.15 (25.37%)
27.3% undervalued intrinsic discount
UK£35.00
Fair Value
UK£25.45
5.15 (25.37%)
20.5% undervalued intrinsic discount
UK£32.00
Fair Value
Price UK£25.45
AnalystHighTarget UK£32.00
AnalystConsensusTarget UK£27.97
AnalystLowTarget UK£18.50

GNS Community Narratives

AnalystHighTarget·
Fair Value UK£35 27.4% undervalued intrinsic discount

Growing Global Protein Demand Will Accelerate Livestock Genetics

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value UK£27.97 9.2% undervalued intrinsic discount

FDA Approval Of PRP Program In 2025 Will Open Significant Revenue Stream

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AnalystLowTarget·
Fair Value UK£18.79 35.1% overvalued intrinsic discount

Regulatory Pressures And Plant-Based Trends Will Erode Future Profitability

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent GNS News & Updates

Genus (LON:GNS) Is Due To Pay A Dividend Of £0.217

Oct 11
Genus (LON:GNS) Is Due To Pay A Dividend Of £0.217

Genus (LON:GNS) Is Due To Pay A Dividend Of £0.217

Sep 07
Genus (LON:GNS) Is Due To Pay A Dividend Of £0.217

There's No Escaping Genus plc's (LON:GNS) Muted Revenues Despite A 25% Share Price Rise

Jul 25
There's No Escaping Genus plc's (LON:GNS) Muted Revenues Despite A 25% Share Price Rise

Estimating The Fair Value Of Genus plc (LON:GNS)

Jul 22
Estimating The Fair Value Of Genus plc (LON:GNS)

Genus plc (LON:GNS) Stock Catapults 36% Though Its Price And Business Still Lag The Industry

May 10
Genus plc (LON:GNS) Stock Catapults 36% Though Its Price And Business Still Lag The Industry

An Intrinsic Calculation For Genus plc (LON:GNS) Suggests It's 21% Undervalued

Apr 18
An Intrinsic Calculation For Genus plc (LON:GNS) Suggests It's 21% Undervalued

Genus plc Key Details

UK£672.8m

Revenue

UK£0

Cost of Revenue

UK£672.8m

Gross Profit

UK£653.5m

Other Expenses

UK£19.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.29
Gross Margin
100.00%
Net Profit Margin
2.87%
Debt/Equity Ratio
46.0%

Genus plc Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Reasonable growth potential with adequate balance sheet.

1 Risk
3 Rewards

About GNS

Founded
1994
Employees
3500
CEO
Jorgen Kokke
WebsiteView website
www.genusplc.com

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. Further, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

U.K. Market Performance

  • 7 Days: -0.8%
  • 3 Months: 5.4%
  • 1 Year: 13.1%
  • Year to Date: 13.6%
The market has been flat in the last week, however the Real Estate sector is down 3.5%. More promisingly, the market is up 13% over the past year. Looking forward, earnings are forecast to grow by 14% annually. Market details ›